Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane for ischemia-reperfusion injury in living donor kidney transplantation
ChiCTR-IPR-14005399Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane in chronic kidney disease (CKD) (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: urine volume, postoperative complications and 15 more. Started Sep 2014; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-IPR-14005399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005399.